Literature DB >> 21345110

Crizotinib in anaplastic large-cell lymphoma.

Carlo Gambacorti-Passerini, Cristina Messa, Enrico M Pogliani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21345110     DOI： 10.1056/NEJMc1013224

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  91 in total

1.  Ceritinib in patients with advanced anaplastic lymphoma kinase-rearranged anaplastic large-cell lymphoma.

Authors:  Heike Richly; Tae Min Kim; Martin Schuler; Dong-Wan Kim; Simon J Harrison; Alice T Shaw; Anthony L Boral; Alejandro Yovine; Benjamin Solomon
Journal:  Blood       Date:  2015-09-03       Impact factor: 22.113

Review 2.  ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern.

Authors:  Kana Sakamoto; Hideki Nakasone; Yuki Togashi; Seiji Sakata; Naoko Tsuyama; Satoko Baba; Akito Dobashi; Reimi Asaka; Chien-Chen Tsai; Shih-Sung Chuang; Koji Izutsu; Yoshinobu Kanda; Kengo Takeuchi
Journal:  Int J Hematol       Date:  2016-01-18       Impact factor: 2.490

3.  Advanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: a report from the children's oncology group.

Authors:  Sarah Alexander; Jacqueline M Kraveka; Sheila Weitzman; Eric Lowe; Lynette Smith; James C Lynch; Myron Chang; Marsha C Kinney; Sherrie L Perkins; Joseph Laver; Thomas G Gross; Howard Weinstein
Journal:  Pediatr Blood Cancer       Date:  2014-08-23       Impact factor: 3.167

4.  The potent oncogene NPM-ALK mediates malignant transformation of normal human CD4(+) T lymphocytes.

Authors:  Qian Zhang; Fang Wei; Hong Yi Wang; Xiaobin Liu; Darshan Roy; Qun-Bin Xiong; Shuguang Jiang; Andrew Medvec; Gwenn Danet-Desnoyers; Christopher Watt; Ewa Tomczak; Michael Kalos; James L Riley; Mariusz A Wasik
Journal:  Am J Pathol       Date:  2013-12       Impact factor: 4.307

5.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

Review 6.  FDG PET/CT imaging as a biomarker in lymphoma.

Authors:  Michel Meignan; Emmanuel Itti; Andrea Gallamini; Anas Younes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-09       Impact factor: 9.236

7.  How "precise" is precision medicine in hematology?

Authors:  Carlo Gambacorti-Passerini; Rocco Piazza
Journal:  Haematologica       Date:  2017-01       Impact factor: 9.941

8.  Malignant transformation of CD4+ T lymphocytes mediated by oncogenic kinase NPM/ALK recapitulates IL-2-induced cell signaling and gene expression reprogramming.

Authors:  Michal Marzec; Krzysztof Halasa; Xiaobin Liu; Hong Y Wang; Mangeng Cheng; Donald Baldwin; John W Tobias; Stephen J Schuster; Anders Woetmann; Qian Zhang; Suzanne D Turner; Niels Ødum; Mariusz A Wasik
Journal:  J Immunol       Date:  2013-11-11       Impact factor: 5.422

9.  Abdominal Pain and Intermittent Fevers in a 16-Year-Old Girl.

Authors:  Kristen Penberthy; Joanne Mendoza; Michael Mendoza; Grant Harrison; Luke Lancaster; Brian Belyea; Steven L Zeichner
Journal:  Pediatrics       Date:  2019-08-02       Impact factor: 7.124

Review 10.  Children's Oncology Group's 2013 blueprint for research: non-Hodgkin lymphoma.

Authors:  Catherine M Bollard; Megan S Lim; Thomas G Gross
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.